Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RELB | hg38_v1_chr19_+_45001430_45001525 | 0.14 | 4.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_74099187 Show fit | 3.56 |
ENST00000508487.3
|
C-X-C motif chemokine ligand 2 |
|
chr4_+_77605807 Show fit | 3.09 |
ENST00000682537.1
|
C-X-C motif chemokine ligand 13 |
|
chr19_+_41877267 Show fit | 2.66 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79a molecule |
|
chr11_+_18266254 Show fit | 2.64 |
ENST00000532858.5
ENST00000649195.1 ENST00000356524.9 ENST00000405158.2 |
serum amyloid A1 |
|
chr2_-_88947820 Show fit | 2.38 |
ENST00000496168.1
|
immunoglobulin kappa variable 1-5 |
|
chr6_-_29559724 Show fit | 2.26 |
ENST00000377050.5
|
ubiquitin D |
|
chr2_-_89320146 Show fit | 2.19 |
ENST00000498574.1
|
immunoglobulin kappa variable 1-39 |
|
chr2_+_89913982 Show fit | 2.01 |
ENST00000390265.2
|
immunoglobulin kappa variable 1D-33 |
|
chr16_+_85899121 Show fit | 1.75 |
ENST00000268638.10
ENST00000565552.1 |
interferon regulatory factor 8 |
|
chr2_-_89100352 Show fit | 1.69 |
ENST00000479981.1
|
immunoglobulin kappa variable 1-16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 14.4 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.3 | 9.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 3.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.8 | 3.1 | GO:2001027 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.3 | 3.0 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 3.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 3.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 2.7 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.3 | 2.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 2.3 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 11.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 3.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 3.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.2 | 3.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 3.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 2.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 2.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 2.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 2.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 16.1 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 5.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 3.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 3.0 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 2.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 2.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 2.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.7 | 2.0 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 3.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 3.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 2.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 2.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 2.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 2.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 2.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 3.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 3.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 2.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 2.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 2.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 2.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 2.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 2.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |